#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome with excess blasts Anti-glomerular basement membrane disease Prodromal Alzheimer's disease Hereditary haemorrhagic telangiectasia Malignant fibrous histiocytoma Systemic candida Congenital ectodermal dysplasia Neurodegenerative disorder Cardiac arrest Cerebellar ataxia Deafness Lymphoma Prolymphocytic leukaemia Lymphatic malformation Congenital pseudarthrosis More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Life with Disease Advanced systemic mastocytosis – Basic Information Primary hyperoxaluria – Basic Information Haemolytic uraemic syndrome – Treatment Biotinidase deficiency – Basic Information Hypereosinophilic syndrome – Diagnostics Metachromatic leukodystrophy – Diagnostics Methylmalonic acidaemia – Treatment Synovial sarcoma metastatic – Basic Information Medulloblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exenatide Vindesine Sulfate Ramucirumab Naloxegol Oxalate Zinc Sulphate Heptahydrate Olanzapine TORASEMIDE HRS 9531 Ep0042 [11C]Az14193391 Insulin Icodec Dacarbazine T89 Mometasone ZOREVUNERSEN SODIUM Senicapoc Ammonium Chloride Saruparib Atrasentan Hydrochloride Ciclosporin More therapies…

    Learn about Your Condition

    Infertility Juvenile absence epilepsy Procedural anxiety Transient ischaemic attack Sciatica Brain abscess Biliary tract operation Nodal osteoarthritis Dyslipidaemia Addison's disease Fatty acid oxidation disorder Tardive dyskinesia Epstein-Barr virus infection Ventricular fibrillation Migraine without aura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometrial cancer metastatic

  • A study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST FOLR1 CONJUGATED TO 1-[(2R,3R,4R,5S,52S)-1,2,3,4,5-PENTAHYDROXY-52-{[(2S)-1-{[(2S)-5-CARBAMOYLAMINO-1-OXO-1-{3-[({[(1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12HBENZO[DE]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-1-YL]CARBAMOYL}OXY)METHYL]ANILINO}PENTAN-2-YL]AMINO}-3-METHYL-1-OXOBUTAN-2-YL]CARBAMOYL}-7-[(2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL]-46,54-DIOXO10,13,16,19,22,25,28,31,34,37,40,43-DODECAOXA-7,47,53-TRIAZANONAPENTACONTAN-59-YL]-2,5-DIOXOPYRROLIDIN-3-YL
    • Doxorubicin Hydrochloride
    • Paclitaxel
    Belgium Denmark Finland France Germany Greece +5

  • A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    Investigated Drugs:
    • Azd8205
    • Doxorubicin
    • Paclitaxel
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Endometrial cancer
    Investigated Drugs:
    • Human Igg1K Monoclonal Antibody Against Tim-3
    • Pemigatinib
    • Retifanlimab
    Belgium France Greece Italy

  • Study of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Durvalumab
    • Tremelimumab
    Spain

  • Study on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endometrial cancer metastatic
    • Endometrial cancer
    • Endometrial cancer recurrent
    Investigated Drugs:
    • Selinexor
    Belgium Czechia Germany Greece Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!